Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice

Kevin J. Morine, Lawrence T. Bish, Klara Pendrak et al. · 2010

Read Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice by Kevin J. Morine, Lawrence T. Bish, Klara Pendrak et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009176.txt.

Description

Kevin Morine and co-authors blocked a muscle brake across the whole body. Their method aimed gene therapy at the liver, and PLOS ONE published it in 2010. Myostatin is a protein that holds muscle mass down throughout life. Blocking it is a hopeful strategy against muscular dystrophy and muscle wasting. Earlier methods needed blockers injected straight into each single muscle.

The team used gene transfer aimed at the liver to make the blocker centrally. The liver then supplied the blocking effect to muscles all over the body. Both normal mice and dystrophic mice received the treatment in this study. One treated organ serving the whole body simplifies future therapy design.

Catalog record

CREATORKevin J. Morine, Lawrence T. Bish, Klara Pendrak et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009176

Browse the full library · About the Tower of Babel